Details of the Drug

General Information of Drug (ID: DMSDYWI)

Drug Name

MKC-1106-PP

Synonyms

E-PRA; E-PSM; Melanoma vaccine, CTL Immunotherapies; Peptide DNA vaccine (cancer), MannKind; Synchrovax vaccine (melanoma), CTL Immunotherapies; Peptide DNA vaccine (PRAME, PSMA), MannKind; [10-Val]PSMA(288-297); Peptide DNA vaccine (preferential antigen of melanoma, prostate-specific membrane antigen), MannKind; [2-norVal, 10-norLeu]PRAME(425-433)

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D Structure is Not Available

3D MOL

2D MOL

Cross-matching ID

TTD ID: D0C9WN

References

1	ClinicalTrials.gov (NCT00423254) Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.. U.S. National Institutes of Health.